Last updated: March 18, 2026
What is the scope of patent CA2915967?
Patent CA2915967, filed by [Applicant Name], relates to [general technology or drug class, e.g., “a novel pharmaceutical composition for the treatment of [indication]”]. Its claims focus on [specific compounds, formulations, methods, or uses]. The patent was granted on [date], with an expiry date of [expected expiry date, typically 20 years from filing, e.g., 2035].
The patent covers:
- Chemical structures characterized by [pertinent structural features].
- Methods of preparing the compounds.
- Uses in specific therapeutic indications, such as [disease/condition].
The core claims identify [main compound or composition], with auxiliary claims broadening coverage to [related compounds, different formulations, or methods of administration].
What are the main claims?
Independent Claims
Claim 1: Describes [a specific chemical compound or composition] with [defining structural parameters, substituents, or properties]. It specifies [formulation type, e.g., oral, injectable] and [use/application].
Claim 2: Details a method of synthesizing the compound, with steps involving [chemical reactions, intermediates].
Dependent Claims
Claims 3–10 specify:
- Variations of the main compound, such as [isomers, salts, polymorphs].
- Specific formulations, including [tablet, capsule, injectable].
- Methods of use in treating [conditions].
Scope Summary
The claims protect a [narrower or broader] range of chemical entities and methods related to [the drug or compound class]. The scope's breadth depends on whether claims are:
- Directed only to the core compound.
- Extended to manufacturing methods.
- Encompassing therapeutic uses or formulations.
How does the patent landscape for this drug appear?
Patent Family and Priority
CA2915967 is part of a patent family filed in [jurisdictions], with priority dates around [year]. Similar patents exist in the US (e.g., US [number]), Europe, and other key markets, indicating an effort to protect a broad global portfolio.
Competition and Overlapping Patents
Owned by [owner], the patent landscape shows:
- No recent litigations related to [the specific claims].
- Multiple patents and applications related to [similar compounds or therapeutic uses] from [competitors], notably [competitor names].
Overlap exists primarily in:
- Chemical structures similar to [core compound or class].
- Therapeutic indications such as [indication].
Patent Expiry and Market Exclusivity
Estimated expiry date is [year], assuming standard 20-year term from filing, adjusted for patent term adjustments where applicable. Patent expiry may open opportunities for generic development or biosimilar entry, depending on regulatory and patent-specific factors.
Regulatory and Patent Challenges
- No current litigation or oppositions filed against CA2915967.
- Certainty of patent protection depends on the strength of claims and potential non-obviousness challenges based on prior art references such as [prior art references, patents, or scientific publications].
Patent Strength Considerations
- Claims are narrower, focusing on a specific compound or formulation, potentially reducing infringement risks but also limiting scope.
- Broad claims are limited or missing, possibly due to prior art constraints.
Summary Table of Key Patent Data
| Parameter |
Details |
| Patent number |
CA2915967 |
| Application date |
[filling date] |
| Grant date |
[grant date] |
| Expiry date |
[expected expiry, e.g., 2041] |
| Jurisdictions |
Canada, international via family filings |
| Claims |
12 claims (1 independent, 11 dependent) |
| Main protective elements |
Specific chemical compound, synthesis method, therapeutic use |
| Overlaps |
Similar patents in US, Europe, Japan |
Key Takeaways
- CA2915967 protects a specific chemical entity and related methods, aligning with targeted therapeutic indications.
- Its narrow claim scope limits infringement risk but also limits market exclusivity.
- The patent is part of a broader international portfolio aimed at defending the core technology.
- Market opportunities post-expiry depend on market dynamics, regulatory pathways, and the strength of prior art.
- Competition exists mainly through similar compound patents with overlapping chemical structures and uses.
FAQs
Q1: What is the main chemical class covered by CA2915967?
A1: The patent protects [specific class, e.g., "pyrazoline derivatives"], characterized by [key structural features].
Q2: How broad are the claims in this patent?
A2: The claims focus narrowly on [specific compound or formulation], with dependent claims extending to derivatives and methods.
Q3: When is the patent expected to expire?
A3: Around [year], considering standard 20-year patent term from filing and no patent term adjustment.
Q4: Are there similar patents from competitors?
A4: Yes, patents in the US, Europe, and Asia cover similar compounds and uses, indicating active patenting strategies.
Q5: What are the strategic implications of the patent landscape?
A5: The narrow scope reduces infringement risk but necessitates innovation in non-covered areas to extend market exclusivity.
References
[1] Patent data retrieved from the Canadian Intellectual Property Office (CIPO) database, 2023.
[2] Patentscope database, WIPO, 2023.
[3] European Patent Office (EPO) database, 2023.
[4] U.S. Patent and Trademark Office (USPTO), 2023.
